It is a pharma private limited company based in New Delhi, Delhi, India, established in 2005.
2005 | New Delhi, Delhi, India | ActiveUttranchal Pharmaceuticals Private Limited, a active private limited company, was established on 08 July 2005 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2005PTC138489. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.15 Cr and a paid-up capital of ₹2.15 Cr.
It upholds a compliant status. Its leadership includes Kathiravanathan (Managing Director), Nitha (Director). Past directors included Suresh Kumar Khurana, Krishan Kumar Nangia, Manoj Kumar Ahuja. It holds ₹8.35 Cr open charges and ₹5.05 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-737 Gali No.24, Sant Nagar Burari, New Delhi, Delhi, 110084.
U24232DL2005PTC138489
138489
08 July 2005
₹2.15 Cr
₹2.15 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Uttranchal Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kathiravanathan | Managing Director | 20 Jan 2015 | Current |
| Nitha | Director | 20 Jan 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Feb 2015 | Past |
| Pramod Abcsdd | Director | 09 Feb 2015 | Past |
| Pramod Abcsdd | Director | 09 Feb 2015 | Past |
| Pramod Abcsdd | Director | 09 Feb 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Uttranchal Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 69.9% increase. The company also saw a substantial fall in profitability, with a 13.26% decrease in profit. The company's net worth moved up by a moderate rise of 4.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Uttranchal Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹83,500,000.00
₹50,512,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2025 | Others | ₹8.35 Cr | Open |
| 27 May 2023 | Axis Bank Limited | ₹2.70 Cr | Satisfied |
| 17 May 2022 | Hdfc Bank Limited | ₹1.42 Cr | Satisfied |
| 16 Jun 2020 | Others | ₹1.31 M | Satisfied |
| 15 Apr 2015 | Punjab National Bank | ₹8.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Uttranchal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Uttranchal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uttranchal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Uttranchal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge registered on 27 May 2023 via Charge ID 100730026 with Axis Bank Limited was fully satisfied on 12 Jun 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 8.35 Cr with Charge ID 101112591 was registered on 28 May 2025. was documented.
Progress on Uttranchal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
A charge registered on 17 May 2022 via Charge ID 100576801 with Hdfc Bank Limited was fully satisfied on 15 Jun 2023. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100730026 was registered on 27 May 2023. was completed.
The CIN of Uttranchal Pharmaceuticals Private Limited is U24232DL2005PTC138489.
Uttranchal Pharmaceuticals Private Limited is headquartered at B-737 Gali No.24, Sant Nagar Burari, New Delhi, Delhi, 110084.
Uttranchal Pharmaceuticals Private Limited was incorporated on 08 July 2005.
The current directors of Uttranchal Pharmaceuticals Private Limited are
The primary industry of Uttranchal Pharmaceuticals Private Limited is Manufacturing.
Uttranchal Pharmaceuticals Private Limited is unlisted.
The authorized capital of Uttranchal Pharmaceuticals Private Limited is ₹2.15 Cr, and the paid-up capital is ₹2.15 Cr.
The compliance status of Uttranchal Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX